
Tempus to Present Four Abstracts at ESMO 2024
Tempus AI, Inc. (NASDAQ: TEM), a leader in using AI for precision medicine, has announced that four of its abstracts have been accepted for the European Society for Medical Oncology (ESMO) Congress 2024. The event will take place in Barcelona,…












